National Bank (TSX: NA) sees Q1 profit rise 23%. A bank stock to bag?

2 min read | February 25, 2022 11:12 AM EST | By Kajal Jain

National Bank (TSX: NA) sees Q1 profit rise 23%. A bank stock to bag? — Image source: © 2022 Kalkine Media Inc

National Bank of Canada (TSX: NA) financial performance in Q1 FY2022

The Montreal-based bank said that its net profit expanded by 22 per cent year-over-year (YoY) to C$ 932 million in Q1 FY2021, while its income before provisions for credit losses (PCL) and taxation was C$ 1.18 billion (compared to C$ 1.04 billion a year ago).

The C$ 34-billion market cap banking company saw its diluted earnings per share (EPS) climb by 23 per cent YoY to C$ 2.65 in the latest quarter.

Also read: Royal Bank (TSX:RY) posts net profit of $4.1B in Q1. Time to buy?

National Bank of Canada also posted a Common Equity Tier 1 (CET1) capital ratio of 12.7 per cent and a leverage ratio of 4.4 per cent under Base III at the end of Q1 FY2021.

National Bank of Canada <a class='font-weight-bold' style='border-bottom: 2px dashed;' aria-label='https://kalkinemedia.com/ca/companies/tsx-na' href='https://kalkinemedia.com/ca/companies/tsx-na'>(TSX:NA)</a> Q1 FY2022 financial results

How has National Bank of Canada stock been performing?

Stocks of National Bank gained by almost 27 per cent in the last one year.

Currently, NM stock is trading nearly 34 per cent above its 52-week low of C$ 75.32 (February 23, 2021) and almost five per cent below its 52-week high of C$ 106.10 (November 22, 2021).

Bottomline

National Bank of Canada, with approval from its Board members, has announced a quarterly dividend of C$ 0.87 apiece for Q1 FY2021, which will be payable on May 1.

Please note, the above content constitutes a very preliminary observation based on the industry, and is of limited scope without any in-depth fundamental valuation or technical analysis. Any interest in stocks or sectors should be thoroughly evaluated taking into consideration the associated risks.

Also read : Can you buy Medicago stock as its vaccine gets Health Canada nod?

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Incorporated (Kalkine Media), Business Number: 720744275BC0001 and is available for personal and non-commercial use only. The advice given by Kalkine Media through its Content is general information only and it does not take into account the user’s personal investment objectives, financial situation and specific needs. Users should make their own enquiries about any investment and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media is not registered as an investment adviser in Canada under either the provincial or territorial Securities Acts. Some of the Content on this website may be sponsored/non-sponsored, as applicable, however, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used in the Content unless stated otherwise. The images/music that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.